FDA-cleared test enables at-home detection of RSV, Flu A/B and COVID in adults and pediatric populations. SAN DIEGO, Jan. 23, 2026 /PRNewswire/ -- ACON Laboratories, Inc. today announced the retail ...

For parents and caregivers, the ability to distinguish between RSV, Flu, and COVID can be critical to determine what treatment path to follow. The Flowflex Plus 4-in-1 test is the first respiratory ...

Flowflex™ is a rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens within 7 days of symptom onset or without any symptoms. This test is easy to use, accurate and is EUA for ...

The Food and Drug Administration (FDA) has cleared ACON Laboratories’ Flowflex COVID-19 Antigen Home Test, the first over-the-counter (OTC) antigen test. Previously, the test was authorized for ...

ACON Laboratories, Inc. announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including respiratory syncytial virus ...